Drug Trial Radar · NCT07197944
Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS
Last checked: Nov 20, 2026Latest source record: Sep 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
90
Planned (sponsor's estimate)
Start
Feb 11, 2026
Primary completion
Oct 23, 2028
Study completion Feb 28, 2032
Sponsor
- Lead sponsor
- Zealand PharmaIndustry
- Sponsor type
- Industry
- First posted
- Sep 30, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the present Phase 3 trial is to confirm the efficacy and safety of glepaglutide 10 mg twice weekly in a patient population with SBS-IF and generate additional long-term safety data. Glepaglutide is the International Nonproprietary Name and United States Adopted Name (USAN) for ZP1848.
Conditions
- Short Bowel Syndrome
Interventions
GlepaglutideDrug
Subcutaneous (SC) injections twice weekly
PlaceboOther
SC injections twice weekly
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in weekly Parenteral Support (PS) volumeTime frame: Baseline to Week 24
Locations
33 sites in 14 countries. Site status is shown where the registry gives one.
The University of Chicago Medicine
Chicago, Illinois · Recruiting
Washington University Center for Advanced Medicine
St Louis, Missouri · Recruiting
Lied Transplant Center at Nebraska Medical Center
Omaha, Nebraska · Recruiting
New York Presbyterian Hospital-Columbia University Medical Center
New York, New York · Not yet recruiting
UPMC Starzl Transplantation Institute
Pittsburgh, Pennsylvania · Recruiting
Vanderbilt University Medical Center
Nashville, Tennessee · Recruiting
Universitätsklinikum AKH Wien
Vienna, State of Vienna, Austria · Recruiting
Universitair Ziekenhuis (UZ) Leuven
Leuven, Belgium · Recruiting
Rigshospitalet-Blegdamsvej 9
Copenhagen, Denmark · Recruiting
Helsingin Yliopistollinen Keskussairaala
Helsinki, Finland · Recruiting
AP-HP - Hôpital Beaujon
Clichy, France · Recruiting
Universitätsklinikum Aachen
Aachen, Germany · Recruiting
Charité - Universitätsmedizin Berlin
Berlin, Germany · Recruiting
Universitätsklinikum Bonn
Bonn, Germany · Recruiting
Asklepios Klinik St. Georg
Hamburg, Germany · Recruiting
Universitätsmedizin Rostock
Rostock, Mecklenburg-Vorpommern, Germany · Recruiting
Eugastro Klinische Studien GmbH
Leipzig, Saxony, Germany · Recruiting
Eszak-Pesti Centrumkorhaz -Honvedkorhaz- Podmaniczky utcai telephely
Budapest, Hungary · Recruiting
Semmelweis Egyetem - Sebészeti, Transzplantációs és Gasztroenterológiai Klinika
Budapest, Hungary · Recruiting
Dél-budai Centrumkórház Szent Imre Egyetemi Oktatókórház
Budapest, Hungary · Recruiting
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico
Milan, Italy · Recruiting
Azienda Ospedale - Università Padova
Padova, Italy · Recruiting
Fondazione Policlinico Universitario A. Gemelli IRCCS - PPDS
Rome, Lazio, Italy · Recruiting
Radboud Universitair Medisch Centrum
Nijmegen, Gelderland, Netherlands · Recruiting
Oslo Universitetssykehus HF, Ullevål
Oslo, Norway · Recruiting
Szpital Skawina sp. z o.o. im. Stanley Dudricka
Skawina, Poland · Recruiting
Samodzielny Publiczny Szpitala Kliniczny im. Prof. Witolda Orlowskiego Centrum Medycznego Kształcenia Podyplomowego
Warsaw, Poland · Recruiting
Wojewodzki Specjalistyczny Szpital im. M. Pirogowa w Lodzi
Lodz, Lódzkie, Poland · Recruiting
Hospital General Universitario Gregorio Marañon
Madrid, Madrid, Spain · Recruiting
Hospital Universitario 12 de Octubre
Madrid, Madrid, Spain · Recruiting
Hospital Universitario Virgen del Rocio - PPDS
Seville, Sevilla, Spain · Recruiting
Sahlgrenska Universitets sjukhuset
Gothenburg, Sweden · Recruiting
Karolinska Universitetssjukhuset Solna
Solna, Sweden · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.